Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators.

A J Cowley, A M Skene

University Hospital, Nottingham.

OBJECTIVES--To determine the effects of enoximone on mortality and quality of life in patients with severe end stage heart failure. DESIGN--A randomised, double blind, placebo controlled trial of the addition of enoximone to conventional treatment. Planned minimum follow up of one year. SETTING--District general hospitals and cardiological referral centres in the United Kingdom. PATIENTS--Planned 200 patients with severe, symptomatic heart failure despite treatment with diuretics and where appropriate and tolerated angiotensin converting enzyme inhibitors and digoxin. RESULTS--The study was ended early by the ethics committee after 151 patients had been recruited because of an excess mortality in the enoximone group: 27 deaths compared with 18 in the placebo group (P < 0.05). Quality of life measured with a disease specific questionnaire showed a clinically significant improvement at week 2 with a mean increase score of 0.48 in the enoximone treated patients compared with 0.14 in those receiving placebo (P = 0.0086). With the Nottingham health profile questionnaire the physical mobility score was improved after three months in the enoximone group, median 21.3 compared with 41.8 in the placebo group (P = 0.008). CONCLUSIONS--In patients with severe heart failure who remain incapacitated despite conventional treatment enoximone reduced survival but had a beneficial effect on the quality of life. Drugs that improve symptoms in severe end stage heart failure should not be discarded lightly.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians

I Sadaf Farooqi, Gareth Beevers, and Gregory Y H Lip
Heart 1995 73: 584. [PDF]

This article has been cited by other articles:

• Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90 [Full Text]  
• Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: 1343-1382 [Full Text]  
• 2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016 [Full Text]  
• 2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479 [Full Text]  
• Taylor, A. L., Ziesche, S., Yancy, C. W., Carson, P., Ferdinand, K., Taylor, M., Adams, K., Olukotun, A. Y., Ofili, E., Tam, S. W., Sabolinski, M. L., Worcel, M., Cohn, J. N., on behalf of the African-American Heart Failure Tr, (2007). Early and Sustained Benefit on Event-Free Survival and Heart Failure Hospitalization From Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine: Consistency Across Subgroups in the African-American Heart Failure Trial. Circulation 115: 1747-1753 [Abstract] [Full Text]  
• Dunderdale, K., Thompson, D. R., Miles, J. N.V., Beer, S. F., Furze, G. (2005). Quality-of-life measurement in chronic heart failure: do we take account of the patient perspective?. Eur J Heart Fail 7: 572-582 [Abstract] [Full Text]  
• Sackner-Bernstein, J. D., Kowalski, M., Fox, M., Aaronson, K. (2005). Short-term Risk of Death After Treatment With Nesiritide for Decompensated Heart Failure: A Pooled Analysis of Randomized Controlled Trials. JAMA 293: 1900-1905 [Abstract] [Full Text]  
• Lalukota, K., Cleland, J. G.F., Ingle, L., Clark, A. L., Coletta, A. P. (2004). Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD. Eur J Heart Fail 6: 953-955 [Abstract] [Full Text]  
• McKenzie, D B, Cowley, A J (2003). Drug therapy in chronic heart failure. Postgrad. Med. J. 79: 634-642 [Abstract] [Full Text]  
• Davidson, P., Introna, K., Daly, J., Paull, G., Jarvis, R., Angus, J., Wilds, T., Cockburn, J., Dunford, M., Dracup, K. (2003). Cardiorespiratory Nurses' Perceptions of Palliative Care in Nonmalignant Disease: Data for the Development of Clinical Practice. Am J Crit Care 12: 47-53 [Abstract] [Full Text]  
• Hobbs, F.D.R., Kenkre, J.E., Roalfe, A.K., Davis, R.C., Hare, R., Davies, M.K. (2002). Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 23: 1867-1876 [Abstract] [Full Text]  
• Doughty, R.N., Sharpe, N. (2002). Optimization of ACE inhibitor therapy in heart failure. Eur Heart J 23: 1322-1323 [Full Text]  
• Houghton, A. R., Harrison, M., Cowley, A. J., Hampton, J. R. (2002). Assessing exercise capacity, quality of life and haemodynamics in heart failure: do the tests tell us the same thing?. Eur J Heart Fail 4: 289-295 [Abstract] [Full Text]  
• Ecochard, R., Colin, C., Rabilloud, M., de Gevigney, G., Cao, D., Ducreux, C., Delahaye, F., PRIMA group, (2001). Indicators of myocardial dysfunction and quality of life, one year after acute infarction. Eur J Heart Fail 3: 561-568 [Abstract] [Full Text]  
• Parsonage, W A, Hetmanski, D, Cowley, A J (2001). Beneficial haemodynamic effects of insulin in chronic heart failure. Heart 85: 508-513 [Abstract] [Full Text]  
• Staniforth, A D, Andrews, R, Harrison, M, Perry, A, Cowley, A J (1998). "Value" of improved treadmill exercise capacity: lessons from a study of rate responsive pacing. Heart 80: 383-386 [Abstract] [Full Text]  
• Jaagosild, P., Dawson, N. V., Thomas, C., Wenger, N. S., Tsevat, J., Knaus, W. A., Califf, R. M., Goldman, L., Vidaillet, H., Connors, A. F. Jr, for the SUPPORT Investigators, (1998). Outcomes of Acute Exacerbation of Severe Congestive Heart Failure: Quality of Life, Resource Use, and Survival. Arch Intern Med 158: 1081-1089 [Abstract] [Full Text]  
• Lee, J.A, Allen, D.G (1997). Calcium sensitisers: mechanisms of action and potential usefulness as inotropes. Cardiovasc Res 36: 10-20 [Full Text]